JPS6143984A - Formed article for tissue culture - Google Patents

Formed article for tissue culture

Info

Publication number
JPS6143984A
JPS6143984A JP59164015A JP16401584A JPS6143984A JP S6143984 A JPS6143984 A JP S6143984A JP 59164015 A JP59164015 A JP 59164015A JP 16401584 A JP16401584 A JP 16401584A JP S6143984 A JPS6143984 A JP S6143984A
Authority
JP
Japan
Prior art keywords
polyarylate
tissue culture
cells
halogen
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59164015A
Other languages
Japanese (ja)
Inventor
Yoshio Toyoda
豊田 芳穂
Kenji Yasue
安江 健治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unitika Ltd
Original Assignee
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unitika Ltd filed Critical Unitika Ltd
Priority to JP59164015A priority Critical patent/JPS6143984A/en
Publication of JPS6143984A publication Critical patent/JPS6143984A/en
Pending legal-status Critical Current

Links

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To provide the titled article having high adhesivity to cells without using the hydrophilic treatment of the surface, and enabling the stable growth and prolideration of cells for a long period, by molding a polyarylate. CONSTITUTION:The objective article can be manufactured by the injection molding of a blent polymer obtained by blending e.g. 30pts. of a polycarbonate with 70pts. of a polyarylate derived from (A) an aromatic dicarboxylic acid preferably composed of terephthalic acid and isophthalic acid at a molar ratio of 7/3-3/7 and (B) a dihydric phenol of formula I [R1-R4 are H, halogen or (halogenated) hydrocarbon group] or formula II [R1'-R4' are same as R1-R4; X is single bond, O, S, SO, CO, (halogen-substituted) alkylene or (halogen-substituted) alkylidene] [e.g. 2,2-bis(4-hydroxyphenyl)propane, etc.].

Description

【発明の詳細な説明】 本発明は1組織培養用成形品に関するものである。[Detailed description of the invention] The present invention relates to a molded article for tissue culture.

組織培養用成形品として、近年、ガラスに代って透明な
合成樹脂の容器やフィルムが多用されるに至っている。
In recent years, transparent synthetic resin containers and films have come into widespread use in place of glass as molded articles for tissue culture.

これらの合成樹脂としてはポリスチレン、ポリメチルメ
タクリレート、ポリ塩化ビニルあるいはこれらの共重合
による変性物が一般的である。しかし、これら合成樹脂
を用いた組織培養用成形品は親水性に欠けるため、この
ままでは、かかる成形品への細胞の接着性が悪く5好ま
しい組織培養ができない。
These synthetic resins are generally polystyrene, polymethyl methacrylate, polyvinyl chloride, or modified products obtained by copolymerization thereof. However, molded articles for tissue culture using these synthetic resins lack hydrophilicity, and if left as is, the adhesion of cells to such molded articles is poor and desirable tissue culture cannot be achieved.

従って、従来より種々の方法にて成形品表面を処理し、
その親水性を高めることが試みられている。例えば親水
性樹脂コーティング、オゾン処理。
Therefore, conventionally, various methods have been used to treat the surface of molded products.
Attempts have been made to increase its hydrophilicity. For example, hydrophilic resin coating, ozone treatment.

コロナ放電処理、酸化剤や鉱酸による処理、プラズマ処
理、β線照射、アルカリ性処理剤による処理、サンドブ
ラスト処理2等が既に知られているしかし、これらの表
面処理は成形品表面に強制的に与えた親水性の経時的低
下および繰り返し使用による低下が大きいため、細胞生
育性及び増殖性について安定したデータが得難り、また
、一旦成形品表面に付着した細胞が生育途中で成形品表
面から剥落する等の欠点を共通して有している。
Corona discharge treatment, treatment with oxidizing agents or mineral acids, plasma treatment, β-ray irradiation, treatment with alkaline treatment agents, sandblasting treatment2, etc. are already known. It is difficult to obtain stable data on cell viability and proliferation due to a large decrease in hydrophilicity over time and repeated use, and cells that have once attached to the surface of a molded product often peel off from the surface during growth. They have common drawbacks such as:

また、処理法によっては成形品表面の細胞に対する毒性
が完全には解消されるには至っておらず細胞の種類によ
ってその生育状態に差が生じるという欠点もある。
Furthermore, depending on the treatment method, toxicity to cells on the surface of the molded article cannot be completely eliminated, and there is also a drawback that the growth state of the cells varies depending on the type of cells.

さらに従来より用いられている組織培養用成形品は一般
に熱変形温度が低いことから組織培養に用いるに当たっ
ては1通常酸化エチレン殺菌をしているが手間を要し、
かつ、コストアンプの原因となっている。
Furthermore, conventionally used molded articles for tissue culture generally have a low heat deformation temperature, so when used for tissue culture they are usually sterilized with ethylene oxide, but this requires time and effort.
Moreover, it is a cause of cost increase.

本発明物らは、上記の如き従来の合成樹脂を用いた組織
培養用成形品の問題点を解消すべく鋭意研究を重ねた結
果、驚くべきことに組織培養用成形品としてボリアリレ
ートを成形したものを用いれば親水性処理を施さすとも
細胞の接着性が良好であって、従って表面処理を施した
従来品にみられるような不安定性がなく、長期にわたっ
て細胞生育、増殖に関して安定したデータが得られると
いう事実を見い出し1本発明に到達したものである。
As a result of intensive research aimed at solving the problems of tissue culture molded products using conventional synthetic resins as described above, the present inventors surprisingly succeeded in molding polyarylate into tissue culture molded products. If a surface-treated product is used, cell adhesion is good even after hydrophilic treatment, and therefore there is no instability seen with conventional products with surface treatment, and stable data on cell growth and proliferation can be obtained over a long period of time. The present invention was based on the fact that the present invention can be obtained.

すなわち本発明は、ボリアリレートを成形してなる組織
培養用成形品である。
That is, the present invention is a molded article for tissue culture formed by molding a polyarylate.

本発明に用いるボリアリレートは、芳香族ジカルボン酸
またはその機能誘導体と二価フェノールまたはその機能
誘導体とより得られるものである。
The polyarylate used in the present invention is obtained from an aromatic dicarboxylic acid or a functional derivative thereof and a dihydric phenol or a functional derivative thereof.

ボリアリレートの調製に用いされる芳香族ジカルボン酸
としては、二価フェノールと反応し満足な重合体を与え
るものであればいかなるものでもよく、1種又は2種以
上混合して用いられる。好ましい芳香族ジカルボン酸と
してはテレフタル酸。
The aromatic dicarboxylic acid used in the preparation of the polyarylate may be any aromatic dicarboxylic acid as long as it reacts with dihydric phenol to give a satisfactory polymer, and may be used alone or in combination of two or more. A preferred aromatic dicarboxylic acid is terephthalic acid.

イソフタル酸があげられるが、特にこれらの混合物が溶
融加工性及び総合的性能の面で好ましい。
Isophthalic acid is mentioned, and mixtures thereof are particularly preferred in terms of melt processability and overall performance.

かかる混合物のとき、その混合比は限定されるものでは
ないが、テレフタル酸/イソフタル酸−9/1〜1/9
(モル比)が好ましく1特に熔融加工性、性能のバラン
スの点で7/3〜3/7(モル比)、更には1/1(モ
ル比)が望ましいボリアリレートの調製に用いられる二
価フェノールとしては、下記一般式(1) 、  (I
t)あるいは(III)で表示されるものがあげられる
In the case of such a mixture, the mixing ratio is not limited, but is terephthalic acid/isophthalic acid -9/1 to 1/9.
(molar ratio) is preferably 1. Particularly from the viewpoint of melt processability and performance balance, 7/3 to 3/7 (molar ratio), and more preferably 1/1 (molar ratio) is divalent used for the preparation of polyarylates. As phenol, the following general formula (1), (I
t) or (III).

上記一般式において、RI + R! + R!* R
4R’+ 、 R’x 、 R’3 + R’4は水素
原子、ハロゲン原子、炭化水素基、ハロゲン化炭化水素
基からなる群より選ばれ、Xはo、s、so、co、ア
ルキレン基あるいはアルキリデン基(若し必要ならばア
ルキレン基あるいはアルキリデン基は1あるいはそれ以
上のハロゲン原子で置換されていてもさしつかえない。
In the above general formula, RI + R! +R! *R
4R'+, R'x, R'3 + R'4 are selected from the group consisting of hydrogen atom, halogen atom, hydrocarbon group, and halogenated hydrocarbon group, and X is o, s, so, co, alkylene group Alternatively, an alkylidene group (if necessary, the alkylene group or alkylidene group may be substituted with one or more halogen atoms).

)を表す。好ましい二価フェノールの具体例としては2
.2−ビス(4−ヒドロキシフェニル)プロパン、2.
2−ビス(4−ヒドロキシ−3,5=ジブロモフエニル
)プロパン、2.2〜ビス(4−ヒドロキー3.5−ジ
クロロフェニル)プロパン、  4.4゛−ジヒドロキ
シジフ−エニルスルホン、  4.4’−ジヒドロキシ
ジフェニルエーテル。
) represents. Specific examples of preferred dihydric phenols include 2
.. 2-bis(4-hydroxyphenyl)propane, 2.
2-bis(4-hydroxy-3,5-dibromophenyl)propane, 2.2-bis(4-hydroxy-3,5-dichlorophenyl)propane, 4.4'-dihydroxydiphenylsulfone, 4.4' -dihydroxydiphenyl ether.

4.4゛−ジヒドロキシジフェニルスルフィイド54.
4゛−ジヒドロキシジフェニルケトン、  4.4’−
ジヒドロキシジフェニルメタン、  2.2’−ビス(
4−ヒドロキー3.5−ジメチルフェニル)プロパン、
1.1−ビス(4−ヒドロキシフェニル)エタン、1.
1−ビス(4−ヒドロキシフェニル)シクロヘキサン、
  4.4’−ジヒドロキシジフェニル。
4.4'-dihydroxydiphenyl sulfide 54.
4′-dihydroxydiphenylketone, 4.4′-
Dihydroxydiphenylmethane, 2,2'-bis(
4-hydroxy3,5-dimethylphenyl)propane,
1.1-bis(4-hydroxyphenyl)ethane, 1.
1-bis(4-hydroxyphenyl)cyclohexane,
4.4'-dihydroxydiphenyl.

ベンゾキノンなどがあげられる。これらは単独で使用し
てもよいし、また2種以上混合して使用してもよい。ま
たこれら二価フェノールはパラ置換体であるが、他の異
性体を使用してもよく、更にこれら二価フェノールにエ
チレングリコール、プロピレングリコールなどを併用し
てもよい。二価フェノールの中で最も代表的なものは、
2.2−ビス(4−ヒドロキシフェニル)プロパン、 
jJLAtビスフェノール八と呼ばへているものであり
、総合的な物面から最も好ましい。
Examples include benzoquinone. These may be used alone or in combination of two or more. Although these dihydric phenols are para-substituted, other isomers may be used, and ethylene glycol, propylene glycol, etc. may be used in combination with these dihydric phenols. The most typical dihydric phenols are
2.2-bis(4-hydroxyphenyl)propane,
It is called JLAt bisphenol 8, and is most preferable from a comprehensive viewpoint.

従って1本発明におけるボリアリレートとじて最も好ま
しいものは、テレフタル酸とイソフタル酸又はこれらの
機能誘導体の混合物(但し、テレフタル酸基とイソフタ
ル酸基のモル比は9;1ないし1:9.特に7:3ない
し3ニア)と一般式(III)で示される二価フェノー
ル、特にビスフェノールA又はその機能誘導体とより得
られるものである。
Therefore, the most preferred polyarylate in the present invention is a mixture of terephthalic acid and isophthalic acid or functional derivatives thereof (provided that the molar ratio of terephthalic acid groups to isophthalic acid groups is 9:1 to 1:9, particularly 7 :3 to 3 nia) and a dihydric phenol represented by the general formula (III), particularly bisphenol A or a functional derivative thereof.

本発明においてはボリアリレート単独のみならず、ボリ
アリレートの樹脂組成物も用いることができる。かかる
樹脂組成物を構成する他の一成分としては、ボリアリレ
ートと相溶性がよくて透明な樹脂組成物を与えるもので
あって、かつ、細胞生育性及び増殖性に悪影響を与えな
いものならば如何なるものでも好ましく用いられるが、
とくにポリカーボネートとポリエチレンテレフタレート
が好ましいものである。かかる樹脂はボリアリレートの
成形性を改良する効果がある。
In the present invention, not only polyarylate alone but also a resin composition of polyarylate can be used. The other component constituting the resin composition may be one that has good compatibility with the polyarylate, provides a transparent resin composition, and does not adversely affect cell growth and proliferation. Anything can be used preferably, but
Particularly preferred are polycarbonate and polyethylene terephthalate. Such a resin has the effect of improving the moldability of polyarylate.

ボリアリレートとポリカーボネートの樹脂組成物を用い
る場合、ボリアリレートの重量分率が50%未満となる
と細胞生育性及び増殖性が低下するのでボリアリレート
の重量分率は50%以上であることが好ましい。ボリア
リレートとポリエチレンテレフタレートの樹脂組成物を
用いる場合も同様の理由からボリアリレートの重量分率
は70%以上であることが好ましい。
When using a resin composition of polyarylate and polycarbonate, if the weight fraction of polyarylate is less than 50%, cell viability and proliferation will decrease, so the weight fraction of polyarylate is preferably 50% or more. When using a resin composition of polyarylate and polyethylene terephthalate, the weight fraction of polyarylate is preferably 70% or more for the same reason.

本発明において成形品とはシャーレ、マルチウェルプレ
ート、細口瓶、広ロ瓶、フラスコ、試験官、ビーカー等
の容器のほか、フィルム、シートを含み、これらは射出
成形、ブロー成形、押出成形、カレンダー成形等の適宜
の成形法によって製造することができる。
In the present invention, molded products include containers such as petri dishes, multi-well plates, narrow-mouth bottles, wide-bottle bottles, flasks, testers, and beakers, as well as films and sheets, and these include injection molding, blow molding, extrusion molding, and calendering. It can be manufactured by an appropriate molding method such as molding.

本発明の組織培養用成形品は、一般に組織培養試験の対
象として用いられるすべての細胞株に対して良好な親水
性表面を有するが、好適に培養し得る代表的な細胞株と
しては例えばHe1a  (ヒト子宮頚部癌)、L (
マウス正常皮下結合組織)。
The tissue culture molded article of the present invention has a hydrophilic surface that is good for all cell lines that are generally used as subjects for tissue culture tests, but representative cell lines that can be suitably cultured include, for example, He1a ( human cervical cancer), L (
mouse normal subcutaneous connective tissue).

[−38(ヒト正常胎児肺)、KB(ヒドロ底層)。[-38 (human normal fetal lung), KB (hydrobasal layer).

Chang Liver  (ヒト正常肝11i)、P
L(ヒト正常羊IIり 、 Don  (チャイニーズ
ハムスター正常肺)。
Chang Liver (human normal liver 11i), P
L (human normal sheep II), Don (Chinese hamster normal lung).

BHK −21(シリアンハムスター正常腎)等を挙げ
ることができる。
Examples include BHK-21 (Syrian hamster normal kidney).

本発明の組織培養用成形品はボリアリレートを用いたも
のであって、従来の表面処理を施したものとは異なり無
処理のため親水性が経時的に低下せず、従って細胞生育
及び増殖性が良好であると共に、長時間にわたって安定
したデータが得られ。
The molded article for tissue culture of the present invention uses polyarylate, and unlike conventional surface-treated articles, its hydrophilicity does not decrease over time because it is not treated, and therefore has good cell growth and proliferation properties. In addition to good performance, stable data can be obtained over a long period of time.

さらに130℃程度の温度によっては全く熱変形を起こ
さないので組織培養を行うに際してガラス容器のように
乾熱滅菌やオートクレーブ滅菌を行うことができるとい
う特徴を有する。
Furthermore, since it does not undergo any thermal deformation at temperatures of about 130° C., it has the characteristic that it can be sterilized by dry heat or autoclave like a glass container when performing tissue culture.

以下実施例をあげて本発明をさらに具体的に説明する。The present invention will be explained in more detail below by giving examples.

実施例1〜3 ■ボリアリレート(ユニチカ■製、UポリマーU−10
0)、■ボリアリレート(同上)とポリカーボネート、
 (奇人化成■製パンライト L−1250)との70
/30(fI重量比からなる樹脂組成物および■ボリア
リレート(同上)とポリエチレンテレフタレート(ユニ
チカ■製、 MA2103)との 80/20(重量比
)からなる樹脂組成物を射出成形して直を蚤75s+m
のシャレーを得た。このシャレーを加熱オーブン中で1
20℃の温度で1時間通風下に滅菌して組織培養に供し
た。尚、この滅菌工程においてシャレーは全く熱変形し
なかった。
Examples 1 to 3 ■Boriaarylate (manufactured by Unitika ■, U-polymer U-10
0), ■Boriaarylate (same as above) and polycarbonate,
(Kijin Kasei Panlight L-1250) and 70
/30 (fI weight ratio) and a resin composition consisting of 80/20 (weight ratio) of polyarylate (same as above) and polyethylene terephthalate (manufactured by Unitika, MA2103) were injection molded and directly molded. 75s+m
Got a chalet. Place this chalet in a heated oven for 1
It was sterilized under ventilation at a temperature of 20° C. for 1 hour and then subjected to tissue culture. Note that the chalet was not thermally deformed at all during this sterilization process.

Eegle MEM培地10+wj!にBovine 
5eru+w  2mj!及び7.5%NaHCO32
m Itを加えて調製した堵養液5ragを培地とし、
これにHe1aS−3細胞(大日本製薬tII製)IX
IO”個を含む液(約1−1)を投与した後、37℃の
保温下、5%炭酸ガス気流中、上記■、■、■それぞれ
31!lづつのシャレーを用いて培養を行なった。培養
を開始して48時間後に0.25%トリプシン液をシャ
レーに加え、シャレー壁面に生育した細胞を壁面から離
脱させて細胞浮遊液とした。この細胞浮遊液中の細胞濃
度をBurker −Turk型血球計算板を用いて測
定したところ培地中の細胞濃度は1 m1当り■の場合
が約1.4X10’ l約1.5X10’及び約1.5
X10B個■の場合が約0.9X10B 1約1.OX
 10”及び約1.5X10”個、■の場合が約0.9
X101i+約1.0X10”及び約1.lX10’含
まれており、それぞれ安定したデータが得られ、シャレ
ー巾で約7.5倍から5倍に増殖したことがかくちにん
された。
Eegle MEM medium 10+wj! Bovine
5eru+w 2mj! and 7.5% NaHCO32
Use 5rag of a nutrient solution prepared by adding m It as a medium,
To this, He1aS-3 cells (manufactured by Dainippon Pharmaceutical tII) IX
After administering a solution containing IO'' cells (approximately 1-1), culturing was carried out under heat at 37°C in a stream of 5% carbon dioxide using chalets each containing 31!L of each of the above ■, ■, and ■. 48 hours after the start of culture, 0.25% trypsin solution was added to the chalet, and the cells that had grown on the wall of the chalet were detached from the wall to form a cell suspension.The cell concentration in this cell suspension was determined by Burker-Turk. When measured using a type hemocytometer, the cell concentration in the medium was approximately 1.4 x 10' per ml, approximately 1.5 x 10' and approximately 1.5 per ml.
In the case of X10B pieces, approximately 0.9X10B 1 Approximately 1. OX
10" and approximately 1.5X10" pieces, approximately 0.9 in the case of ■
X101i + approximately 1.0X10'' and approximately 1.1X10', stable data were obtained for each, and it was confirmed that the cells multiplied approximately 7.5 to 5 times in the width of the chalet.

つぎに、上記で一度使用したシャレーを水洗後。Next, after washing the chalet that was used once above.

上記の場合と同様に滅菌してくり返し培養試験をおこな
った。その結果、■の場合が1.4X10”。
The cells were sterilized and repeated culture tests were conducted in the same manner as above. As a result, the case of ■ is 1.4X10".

約1.5X10”および約1.6X10B個、■の場合
が約1.0X10” l約1.0X10”および約1.
lX10”個、■の場合が約1.lXl0’ l約1.
lX10”および約1.2X to’ tlJのデータ
が得られ、くり返し使用に際しても安定した値かえられ
ることが確認された。
Approximately 1.5X10'' and approximately 1.6X10B pieces;
lX10'' pieces, ■ case is approximately 1.lXl0'l approximately 1.
Data of 1X10" and about 1.2X to' tlJ were obtained, and it was confirmed that stable values could be changed even after repeated use.

特許出願人  ユニチカ株vct社 −AAF、−Patent applicant: Unitika Co., Ltd. VCT -AAF,-

Claims (1)

【特許請求の範囲】[Claims] (1)ポリアリレートを成形してなる組織培養用成形品
(1) A molded article for tissue culture made of polyarylate.
JP59164015A 1984-08-03 1984-08-03 Formed article for tissue culture Pending JPS6143984A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59164015A JPS6143984A (en) 1984-08-03 1984-08-03 Formed article for tissue culture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59164015A JPS6143984A (en) 1984-08-03 1984-08-03 Formed article for tissue culture

Publications (1)

Publication Number Publication Date
JPS6143984A true JPS6143984A (en) 1986-03-03

Family

ID=15785157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59164015A Pending JPS6143984A (en) 1984-08-03 1984-08-03 Formed article for tissue culture

Country Status (1)

Country Link
JP (1) JPS6143984A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200040102A (en) * 2018-10-08 2020-04-17 한온시스템 주식회사 Air conditioner for vehicle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5712992A (en) * 1980-06-26 1982-01-22 Sekisui Chem Co Ltd Molded article for tissure culture

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5712992A (en) * 1980-06-26 1982-01-22 Sekisui Chem Co Ltd Molded article for tissure culture

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200040102A (en) * 2018-10-08 2020-04-17 한온시스템 주식회사 Air conditioner for vehicle

Similar Documents

Publication Publication Date Title
JP3383311B2 (en) High impact products obtained from polyester blends
Yu et al. Tyrosine–PEG-derived poly (ether carbonate) s as new biomaterials: Part I: synthesis and evaluation
US4686245A (en) High energy irradiated polycarbonates containing organic borates
JPH11315191A (en) Polyester molding composition
JPH09500676A (en) Copolyesters having repeating units derived from succinic acid
JPS62501851A (en) Elastomer composition
Dai et al. Fibroblast aggregation by suspension with conjugates of poly (ethylene glycol) and RGD
JP4868650B2 (en) Polyarylate resin composition and molded article comprising the same
Miwa et al. Poly (adenosine diphosphate ribose) synthesis during the cell cycle of transformed hamster lung cells
JPH09501713A (en) Shrinkable copolyester film
JPH0733438B2 (en) Sterile article manufacturing method
JP2007512415A (en) Ionizing radiation stable polyaryl ester carbonate composition
JPS5936154A (en) Oven dish of talc-containing plastic
JPS6143984A (en) Formed article for tissue culture
JPH11279389A (en) Polyester molding composition
EP1212374B1 (en) Sound damping polyester molding compositions
JP2713784B2 (en) Thermoplastic molding compound
EP0353776B1 (en) Polycarbonate composition
JP5567560B2 (en) Blend of polyester and ABS copolymer
JPH01103659A (en) Blendable compound of polycarbonate and styrene copolymer
US4965303A (en) Polycarbonate composition
JPS6227701A (en) Transparent molding for optical device
JPS5871884A (en) Vessel for cell culture
JP3038788B2 (en) Polycarbonate resin composition and medical parts using the same
JP2002508420A (en) X-ray impervious thermoplastic molding composition